Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating
MT NewswiresMar 19 21:30
Baird Maintains Outperform on Leap Therapeutics, Lowers Price Target to $9
BenzingaMar 19 19:09
Leap Therapeutics Analyst Ratings
BenzingaMar 19 18:46
HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target
BenzingaMar 19 18:48
Leap Therapeutics: Promising Clinical Outcomes and Upcoming Catalysts Bolster Buy Rating
TipRanksMar 19 18:19
Maintaining Buy Rating on Leap Therapeutics: Promising DKN-01 Trials and Undervalued Market Potential
TipRanksJan 26 13:49
Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), Leap Therapeutics (LPTX)
TipRanksJan 26 13:42
Outperform Rating on Leap Therapeutics Amid Promising Gastric Cancer Trial Outcomes
TipRanksJan 26 13:40
Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), Outlook Therapeutics (OTLK) and Leap Therapeutics (LPTX)
TipRanksJan 24 19:41
Analysts Offer Insights on Healthcare Companies: Codexis (CDXS), Leap Therapeutics (LPTX) and Sutro Biopharma (STRO)
TipRanksJan 23 04:50
Leap Therapeutics (LPTX) Gets a Buy From Piper Sandler
TipRanksJan 23 03:50
Optimism High as Leap Therapeutics' Studies Suggest Potential for Significant Shareholder Value
TipRanksJan 5 13:45
Leap Therapeutics (LPTX) Receives a Buy From Piper Sandler
TipRanksJan 3 20:51
Leap Therapeutics Analyst Ratings
BenzingaNov 20, 2023 23:38
Financial Analyst Maintains Buy Rating for Leap Therapeutics: A Look Into Q3 2023 Results and Future Clinical Data Updates
TipRanksNov 14, 2023 19:34
Raymond James Maintains Outperform on Leap Therapeutics, Lowers Price Target to $17.5
BenzingaNov 14, 2023 16:42
Leap Therapeutics Analyst Ratings
BenzingaNov 14, 2023 16:41
HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Raises Price Target to $7
BenzingaAug 15, 2023 18:50
Leap Therapeutics Analyst Ratings
BenzingaAug 15, 2023 18:49
Leap Therapeutics (LPTX) Receives a Buy From H.C. Wainwright
TipRanksAug 15, 2023 18:25
No Data
No Data